New Key Statistics Module, Z-Score and F-Score
NYSE:CRL Key Ratios
Market Cap $ M | 10,953.37 |
Enterprise Value $ M | 13,502.69 |
P/E(ttm) | 25.59 |
PE Ratio without NRI | 18.74 |
Forward PE Ratio | 20.58 |
Price/Book | 2.97 |
Price/Sales | 2.71 |
Price/Free Cash Flow | 22.71 |
Price/Owner Earnings | 22.51 |
Payout Ratio % | -- |
Revenue (TTM) $ M | 4,077.00 |
EPS (TTM) $ | 8.37 |
Beneish M-Score | -2.71 |
10-y EBITDA Growth Rate % | 15.20 |
5-y EBITDA Growth Rate % | 15.20 |
y-y EBITDA Growth Rate % | -4.60 |
EV-to-EBIT | 20.00 |
EV-to-EBITDA | 13.42 |
PEG | 1.23 |
Shares Outstanding M | 51.14 |
Net Margin (%) | 10.59 |
Operating Margin % | 13.78 |
Pre-tax Margin (%) | 13.25 |
Quick Ratio | 1.21 |
Current Ratio | 1.58 |
ROA % (ttm) | 5.44 |
ROE % (ttm) | 12.32 |
ROIC % (ttm) | 6.32 |
Dividend Yield % | -- |
Altman Z-Score | 2.81 |
CRL Number of Guru Trades
CRL Volume of Guru Trades
Gurus Latest Trades with NYSE:CRL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:CRL is held by these investors
Total 3
Charles River Laboratories International Inc Insider Transactions
No Available Data
News about NYSE:CRL
Total 0- 1